Bio Usawa Inc.

Bio Usawa is a biotechnology company dedicated to democratizing access to life-saving biotherapeutics across Africa. The company focuses on developing and manufacturing affordable, high-quality monoclonal antibodies and biosimilars targeting cancer, diabetes complications, infectious diseases, and autoimmune conditions. Bio Usawa is pioneering a model of local biomanufacturing in Africa using proprietary modular manufacturing technology (BioMod™). By integrating discovery, development, and manufacturing into a connected ecosystem, the company aims to reduce dependence on imported biologics, shorten supply chains, and build sustainable, locally empowered biotechnology infrastructure.